cepheid-logo

Scalable PCR Testing with Easy & Standardized Workflows

Eliminate Send-outs. Improve Operational Efficiencies

 

For a higher level of PCR excellence

 

fast Fast, actionable data with most test results in less than an hour and respiratory test results in as little as 30 minutes*
accurate Highly accurate PCR results for consistent patient management across the continuum of care
on-demand On-demand and random-access allows tests to be performed when needed rather than being delayed for batch testing

 

Cepheid provides a higher level of PCR excellence that is designed to deliver speed, accuracy, and peace of mind.

 

GeneXpert C difficile

Tests from Cepheid that can help you meet today’s infection control challenges

 

Carba R PCR Antimicrobial resistance (AMR) including multidrug-resistant organism (MDRO)

Carbapenem Resistance (KPC, NDM, VIM, OXA-48 and IMP)

  • Xpert® Carba-R PCR test is a qualitative and on-demand test for the detection and differentiation of KPC, NDM, VIM, OXA-48 and IMP in 50-minutes. 

Vancomycin-Resistant Enterococci (VRE)

  • Xpert®vanA is the first rapid and accurate test to assist with VRE surveillance in around 45 minutes.§
Healthcare-Associated Infections Healthcare Associated Infections (HAIs)

Central Line- Associated Bloodstream Infection (CLABSI)

  • Xpert® MRSA/SA Blood Culture. Cepheid's MRSA PCR test provides detection of MRSA and MSSA in positive blood cultures in about an hour. Download brochure » 

Clostridioides difficile Infection (CDI)

  • Xpert®C. difficile/Epi on-demand testing of samples from suspected CDI patients supports diagnosis and epidemiological surveillance to support clinical decisions. 

Surgical Site Infection (SSI)

  • Xpert® SA Nasal Complete supports pre-surgical testing of S. aureus and MRSA in about an hour. 
CT/NG testing Disease/Organism
Chlamydia trachomatis and Neisseria gonorrhoeae
  • Xpert® CT/NG testing detects and differents Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) in 90 minutes.

Clostridioides difficile (C. diff)

  • Xpert®C. difficile/Epi allows on-demand testing of samples from suspected CDI patients provides epidemiological surveillance data to support clinical decisions.

Enterococcus (Vancomycin-Resistant)

  • Xpert®vanA is the first rapid & accurate test to assist with VRE surveillance in around 45 minutes.§

Influenza and/or COVID-19

  • Xpert® Xpress CoV-2/Flu/RSV plus^,# helps to rapidly differentiate flu, RSV, and SARS-CoV-2 and potential co-infections with SARS-CoV-2 positive results in as little as 25 minutes.
  • Xpert® Xpress CoV-2 plus^,# contains three gene targets for a rapid, robust detection of SARS-CoV-2, positives in as soon as 20 minutes.‡ Download brochure »

Methicillin Susceptible Staphylococcus aureus (MSSA) and/or Methicillin Resistant Staphylococcus aureus (MRSA)

  • Xpert® MRSA/SA Blood Culture detects MRSA and MSSA in positive blood cultures in about an hour. Download brochure »
  • Xpert® SA Nasal Complete supports pre-surgical testing of S. aureus and MRSA in about an hour. 
  • Xpert® MRSA NxG provides accurate, fast, on-demand PCR test that detects MRSA directly from nasal swabs in around 45 minutes.§ Download brochure »
  • Xpert® MRSA/SA SSTI detects MRSA & S. aureus skin and soft tissue infections in about an hour. Download brochure »

Mycobacterium tuberculosis (MTB)

  • Xpert® MTB/RIF provides accurate detection of MTB and rifampin resistance mutations in less than two hours.

Norovirus

  • Xpert® Norovirus provides high sensitivity and specificity with results in as little as one hour, delivering accurate and actionable results for clinical decisions.§

References

All tests listed are non-waived unless otherwise stated.
* Test times may vary, refer to product package insert for testing time details.
^ In Vitro Diagnostic devices for use in High and Moderate Complexity or CLIA waived patient care settings. See Package Inserts for details.
# These tests have not been FDA cleared or approved. These tests have been authorized by FDA under an EUA for use by authorized laboratories. Xpert Xpress CoV-2 plus has been authorized only for the detection of nucleic acids from SARS-CoV-2, and not for any other viruses or pathogens. Xpert Xpress CoV-2/Flu/RSV plus has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acids from SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV), and not for any other viruses or pathogens. The emergency use of these products is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
† For positives when running SARS-CoV-2 only, using Xpert Xpress CoV-2/Flu/RSV plus; otherwise, the test will have a runtime of approximately 36 minutes.
‡ With early assay termination (EAT) for positive results; otherwise, the full test runtime is approximately 30 minutes.
§ With early assay termination (EAT) for positive results.

US-IVD. In Vitro Diagnostic Medical Device

Improve Your Lab Efficiency

*required fields
Cepheid respects your privacy, and values the relationship with our customers, partners, and associates. Your personal data may be processed by Cepheid, its affiliates, representatives and other Danaher companies for business and marketing purposes. You can review Cepheid Privacy Policy online for additional information on your rights and how we use and share personal data we collect on our websites and other channels. Your consent to receiving Cepheid news can be withdrawn at any time. Building a relationship of trust is important to us and we will happily help with any questions on your personal data processing addressed to Privacy.officer@cepheid.com

.